These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7651889)

  • 21. Surprising pharmacological activity of analogues designed by substitution of position 3 in arginine vasopressin (AVP) and 8-D-arginine vasopressin with L-2-napthylalanine.
    Lammek B; Konieczna E; Trzeciak HI; Kozłowski A; Szymkowiak J; Stojko R; Kupryszewski G
    J Pharm Pharmacol; 1996 Mar; 48(3):316-9. PubMed ID: 8737061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids.
    Stoev S; Cheng LL; Olma A; Klis WA; Manning M; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1999 Mar; 5(3):141-53. PubMed ID: 10323558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
    Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors.
    Chan WY; Wo NC; Stoev S; Cheng LL; Manning M
    Br J Pharmacol; 1998 Oct; 125(4):803-11. PubMed ID: 9831918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressin.
    Kowalczyk W; Prahl A; Derdowska I; Dawidowska O; Slaninová J; Lammek B
    J Med Chem; 2004 Nov; 47(24):6020-4. PubMed ID: 15537356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal absorption and plasma clearance rates of [D-Arg8]vasopressin analogues in the rat.
    Lundin S; Folkesson HG; Pierzynovski SG; Bengtsson HI
    Peptides; 1994; 15(5):809-14. PubMed ID: 7984498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the role of adenylate cyclase in the release of adrenocorticotropin from the ovine and rat anterior pituitary.
    Liu JP; Robinson PJ; Funder JW; Engler D
    Mol Cell Endocrinol; 1994 May; 101(1-2):173-81. PubMed ID: 9397950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
    Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C; Rivier J; Mormede P; Vale W
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of rat kidney adenylate cyclase by vasopressin analogues: lack of correlation with antidiuretic activity.
    Barth T; Rajerison MR; Roy C; Jard S
    Mol Cell Endocrinol; 1975 Jan; 2(2):81-90. PubMed ID: 1149917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of L-naphthylalanine in position 3 of AVP and its analogues on their pharmacological properties.
    Lammek B; Czaja M; Derdowska I; Rekowski P; Trzeciak HI; Sikora P; Szkróbka W; Stojko R; Kupryszewski G
    J Pept Res; 1997 Mar; 49(3):261-8. PubMed ID: 9151259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressin and oxytocin receptors coupled to Ca2+ mobilization in rat inner medullary collecting duct.
    Maeda Y; Han JS; Gibson CC; Knepper MA
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F15-25. PubMed ID: 8393622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro adrenocorticotropin/beta-endorphin-releasing activity of vasopressin analogs is related neither to pressor nor to antidiuretic activity.
    Knepel W; Homolka L; Vlaskovska M; Nutto D
    Endocrinology; 1984 May; 114(5):1797-804. PubMed ID: 6325132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
    J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor.
    Saito M; Tahara A; Sugimoto T
    Biochem Pharmacol; 1997 Jun; 53(11):1711-7. PubMed ID: 9264324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for dual signaling pathways for V2 vasopressin receptor in rat inner medullary collecting duct.
    Ecelbarger CA; Chou CL; Lolait SJ; Knepper MA; DiGiovanni SR
    Am J Physiol; 1996 Apr; 270(4 Pt 2):F623-33. PubMed ID: 8967340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent V2/V1a vasopressin antagonists with C-terminal ethylenediamine-linked retro-amino acids.
    Manning M; Przybylski J; Grzonka Z; Nawrocka E; Lammek B; Misicka A; Cheng LL; Chan WY; Wo NC; Sawyer WH
    J Med Chem; 1992 Oct; 35(21):3895-904. PubMed ID: 1433200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin potentiates cyclic AMP accumulation and ACTH release induced by corticotropin-releasing factor (CRF) in rat anterior pituitary cells in culture.
    Giguere V; Labrie F
    Endocrinology; 1982 Nov; 111(5):1752-4. PubMed ID: 6290198
    [No Abstract]   [Full Text] [Related]  

  • 40. Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells.
    Perdonà E; Arban R; Griffante C
    Eur J Pharmacol; 2012 Mar; 679(1-3):16-23. PubMed ID: 22285855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.